logo/base Created with Sketch.

FibroScan® probes

Optimize measurement accuracy on all patient morphologies

Choose the appropriated probe between S+, M+ or XL+.

wave

Optimize measurement accuracy

FibroScan® offers a range of 3 probes (S+, M+ and XL+) designed to fit patient morphology.  

By adjusting the measurement area relative to the distance between the probe and the liver (Probe to Capsula Distance) a consistent explored volume can be maintained.

Which FibroScan® probe is adapted to your patient?

S+ probe

M+ probe 

XL+ probe 

For pediatric population

Designed for being placed into narrow intercostal space

For patients
with standard morphotype

 

For patients with obesity
and extreme obesity

Designed to enhance signal penetration
through deeper tissues

Measurement depth

From 15 to 50 mm

Measurement depth

From 25 to 70 mm
with Guided VCTE™

Measurement depth

From 35 to 85 mm
with Guided VCTE™

Criteria of selection

Age < 18yo
and Thoracic Perimeter ≤ 75 cm

 

Criteria of selection

Age < 18yo
and Thoracic Perimeter > 75 cm

or Age ≥ 18yo
and no XL+ probe recommendation

Criteria of selection

Age ≥ 18ans et
pas de recommandation sonde M+

 

For M+ and XL+ probes, FibroScan® automatically recommends the right probe.

 

Probes selection criteria

To ensure that the probe is adapted to the patient’s morphology, please read the FibroScan® examination procedure.

What our users say

quote

The obese population that we receive for FibroScan® examinations has increased substantially in recent years. CAP™ has become essential to our prescribers to precisely monitor patient’s steatosis. SmartExam allows us to address difficult patients and to provide reliable results to our prescribers.

FibroScan® nurse referent | Cochin University Hospital, Paris, France

chevron chevron

FibroScan® comes with the standard M+ probe.

S+ and XL+ probes are available as an option.

Products in the FibroScan® range are Class IIa medical devices as defined by Directive 93/42/EEC (EC 0459). These devices are designed for use in a medical practice in order to measure liver stiffness and ultrasound attenuation in patients with liver disease. Examinations with FibroScan® device shall be performed by an operator who has been certified by the manufacturer or its approved local representative. Operators are expressly recommended to carefully read the instructions given in the user manual and on the labelling of these products. Check cost defrayal conditions with paying bodies.